Litigation Details for United Therapeutics Corporation v. Liquidia Technologies, Inc. (D. Del. 2020)

United Therapeutics Corporation v. Liquidia Technologies, Inc. (D. Del. 2020)

Docket		Date Filed	2020-06-04
Court	District Court, D. Delaware	Date Terminated	2022-09-09
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To	Jennifer L. Hall
Parties	UNITED THERAPEUTICS CORPORATION
Patents	6,521,212; 6,756,033; 6,765,117; 7,417,070; 7,544,713; 7,999,007; 8,497,393; 9,339,507; 9,358,240; 9,593,066; 9,604,901
Attorneys	Jack B. Blumenfeld
Firms	Morris, Nichols, Arsht & Tunnell, LLP
Link to Docket	External link to docket

Details for United Therapeutics Corporation v. Liquidia Technologies, Inc. (D. Del. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2021-06-04	108	Redacted Document	the validity of patents related to the Patents-in-Suit, such as U.S. Patent Nos. 8,497,393 (“the ’393…concerning [U.S. Patent No. 8,497,393] in association with the ’901 and ’066 patents,” asserting that…concerning the Related Patents and Applications, including U.S. Patent Nos. 8,497,393; 9,339,507; 9,358,…PTAB's 4 The '393 patent is U.S. Patent No. 8,497,393. Case 1:20-cv-00755-RGA-JLH Document…Hatch‐Waxman litigation involving the Patents‐in‐Suit and U.S. Patent Nos. 8,497,393; 9,339,507; and 9,358,240,	External link to document
2021-06-04	109	Ex. 1 - Second Amended Complaint	seq., involving United States Patent Nos. 9,593,066 (“the ’066 patent”) (attached as Exhibit A hereto…the expiration of the ’066 patent, the ’901 patent, and the ’793 patent, to manufacture, market, and… more claims of the ’066 patent, the ’901 patent, and the ’793 patent, which have been listed in …Liquidia has infringed the ’066 patent, the ’901 patent, and the ’793 patent; and …or more of the ’066 patent, the ’901 patent, and the ’793 patent, prior to the expiration	External link to document